Sizing accuracy and intra-assay precision of DLS measurements with Prometheus Panta

November 13, 2020

Scientists in the field of drug discovery, particularly biologics, use DLS to make critical decisions about drug candidate stability. This creates a need for instruments that exhibit strong sizing accuracy and precision. These properties can be evaluated using standards and references from the National Institute of Standards and Technology (NIST). Here, the NIST monoclonal antibody (NISTmAb) reference material (RM) RM8671, Lysozyme, and a set of monodisperse particle size standards were used to test the sizing accuracy and intra-assay precision of Prometheus Panta’s DLS optical module.

Previous Article
Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates
Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates

Up next
Use of high-throughput methods for early stage formulation evaluation and their correlation to stability studies
Use of high-throughput methods for early stage formulation evaluation and their correlation to stability studies

AbbVie preformulation is an early discovery biologics group working to optimise antibodies prior to downstr...

Have a question about Prometheus?

Contact Specialist